TOKYO -- Japanese vaccine makers are racing to release COVID vaccines next year as they anticipate new virus variants and further outbreaks.
COVID vaccines
Japanese drugmakers race to release COVID vaccines
KM Biologics and Daiichi Sankyo follow Shionogi in inoculation drive
Japanese vaccine makers are rushing to conduct Phase 2/3 trials of vaccines, aiming to put them in the market next year. (Nikkei photo)
Read Next
Latest on COVID vaccines
